Skip to Content

Big R&D Job Cuts at GlaxoSmithKline

Reuters/International Herald Tribune and the Wall Street Journal (subscription required for WSJ access) are reporting that GlaxoSmithKline intends to cut 850 research and development (R&D) jobs in the United States and the United Kingdom–6% of Glaxo’s R&D staff. These job cuts are on top of 350 announced earlier this year, meaning that Glaxo is eliminating 8+% of their R&D workforce.

One comment on “Big R&D Job Cuts at GlaxoSmithKline”

  1. Mia says:

    R&D is an important sector for development. However, job slash is happening everywhere due to recession.more are yet to come i guess..

Comments are closed.